People with high blood pressure that is uncontrolled or poorly treated with most medications may benefit from a new drug that is showing promise in clinical trial results, according to a study ...
Bioinformatics, Epidemiology, and Lp(a) Center for Research and InnOvatioN
News
UC San Diego BEACON in the news
Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are preventive changes you can make today.
|
January 29, 2025 – Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S. measuring lipoprotein (a), or Lp(a), in nanomoles per liter (nmol/L). The National Lipid Association (NLA) recommends all adults ...
|